Skip to content

Glossary

Plain-English meanings of the 34 regulatory and clinical trial terms used on Psychedelic Monitor. Each entry says what a term means, not whether a treatment works. In summaries, the first use of a term has a dotted underline.

A

adverse event
Any unwanted medical occurrence in a trial participant, whether or not it was caused by the treatment. Also written: adverse events.
ANZCTR
The Australian New Zealand Clinical Trials Registry, a public register of clinical trials.
ARTG
The Australian Register of Therapeutic Goods, the list of therapeutic goods that can lawfully be supplied in Australia. Also written: Australian Register of Therapeutic Goods.
Authorised Prescriber
A TGA scheme under which an approved medical practitioner can prescribe a named unapproved medicine to a defined group of their patients. Also written: Authorised Prescriber scheme, Authorised Prescribers.

B

breakthrough therapy designation
An FDA status that speeds up the development and review of a drug for a serious condition; it is not an approval. Also written: Breakthrough Therapy designation.

C

ClinicalTrials.gov
A public register of clinical trials run by the US National Library of Medicine; its trial numbers start with NCT.

D

double-blind
A study in which neither participants nor the researchers assessing them are told who received which treatment. Also written: double blind, double-blinded.

E

EMA
The European Medicines Agency, which evaluates medicines for the European Union. Also written: European Medicines Agency.

F

FDA
The Food and Drug Administration, the United States regulator of medicines, medical devices and food. Also written: Food and Drug Administration.

H

HREC
A Human Research Ethics Committee, the Australian body that reviews research involving people before it can start. Also written: Human Research Ethics Committee.

I

IND
An investigational new drug application, which must be in effect with the FDA before a new drug is tested in people in the United States. Also written: investigational new drug application.

M

MBS item
A health service listed on the Medicare Benefits Schedule, for which Medicare pays a rebate. Also written: MBS items, Medicare Benefits Schedule.
meta-analysis
A statistical method that combines the results of several studies into one estimate. Also written: meta-analyses, meta analysis.

N

NDA
A new drug application, the formal request asking the FDA to approve a new medicine for sale in the United States. Also written: new drug application.

O

open-label
A study in which participants and researchers both know which treatment is being given. Also written: open label.

P

PBS
The Pharmaceutical Benefits Scheme, the Australian Government program that subsidises the cost of listed medicines. Also written: Pharmaceutical Benefits Scheme.
peer review
Checking of a research paper by independent experts in the field before a journal publishes it. Also written: peer-reviewed, peer reviewed.
Phase 1
The first studies of a drug in people, usually in small numbers, looking mainly at safety and dose. Also written: Phase I, Phase 1a, Phase 1b.
Phase 2
Mid-stage trials in people with the condition, looking at dose, safety and early signs of effect. Also written: Phase II, Phase 2a, Phase 2b.
Phase 3
Larger trials meant to confirm a drug's effects and safety, usually needed before a regulator will consider approving it. Also written: Phase III.
placebo-controlled
A study that compares the treatment with an inactive or low-dose look-alike, called a placebo.
Poisons Standard
The Australian legal instrument that sorts medicines and chemicals into schedules, which set how each can be supplied.
preprint
A research paper shared publicly before it has been peer reviewed. Also written: preprints.
primary endpoint
The main result a trial is designed to measure, chosen before the trial starts. Also written: primary endpoints, primary outcome.
PTSD
Post-traumatic stress disorder, a mental health condition that can follow exposure to a traumatic event. Also written: post-traumatic stress disorder, posttraumatic stress disorder.

R

RCT
A randomised controlled trial, in which participants are assigned by chance to the treatment being tested or to a comparison. Also written: randomised controlled trial, randomized controlled trial, randomised controlled trials, randomized controlled trials.
rescheduling
Moving a substance to a different schedule in drug-control or poisons law, which changes how it can be supplied and used. Also written: rescheduled, reschedule, reschedules.

S

Schedule 8
The Poisons Standard category for controlled drugs: medicines that can be prescribed, under tighter controls than ordinary prescription medicines.
Schedule 9
The Poisons Standard category for prohibited substances, which can be used only in approved research, teaching or analysis.
Special Access Scheme
A TGA pathway that lets a health practitioner seek access to an unapproved therapeutic good for a single patient.
systematic review
A review that uses a stated, repeatable method to find and assess all the studies on a question. Also written: systematic reviews.

T

TGA
The Therapeutic Goods Administration, Australia's national regulator of medicines and medical devices. Also written: Therapeutic Goods Administration.
topline results
A first summary of a trial's main outcomes, usually released by the sponsor before full data are published or peer reviewed. Also written: top-line results, topline data, top-line data.
treatment-resistant depression
Depression that has not improved enough after adequate courses of at least two antidepressant treatments. Also written: TRD.

These are general definitions, not medical or legal advice. About this site